03 September 2019

2nd Repeat Extraordinary General Meeting

The detailed agenda of the 2nd Repeat Extraordinary General Meeting of the Company’s shareholders scheduled for 03.09.2018 is available here. The proxy statement form is available here. The Report of the Board of Directors of the Company to shareholders is available here.

This is the summary version of the published invitation to the Company’s shareholders:

I N V I T A T I O N

Shareholders of J&P-AVAX SA are invited to a

REPEAT EXTRAORDINARY GENERAL MEETING

In accordance with Corporate Law 2190/1920 and its amendments, as well as the Company Charter, the Board of Directors of J&P-AVAX SA (the “Company”) with its decision dated August 17, 2018 invites shareholders to a Second Extraordinary General Meeting on Monday, September 03, 2018 at 13:00 at the Company headquarters, located at 16 Amarousiou-Halandriou Street in Marousi, Greece to discuss the following agenda:

AGENDA

1. Decrease of the nominal value of each common share from €0.58 to €0.30, resulting in the decrease of the nominal value of the Company’s share capital by €21,743,358.00, capitalising an equal amount of accumulated losses.

2. Increase of the share capital of the Company up to the amount of twenty million euro (€20,000,000.00) through a cash issue offering rights of participation to all its shareholders, at an issue price of €0.45 per share for a total of 44,444,444 new common shares

3. Amendment of article 5 of the Corporate Charter.

According to article 26, paragraphs 2 and 2b, and article 28a of Corporate Law 2190/1920 and its amendments, the Company informs its shareholders as follows:

I. PARTICIPATION AND VOTING RIGHTS TO THE GENERAL METING

Participation and voting rights to the September 03, 2018 Second Repeat Extraordinary General Meeting are offered to shareholders recorded on the Electronic Registry System of “Hellenic Exchanges SA”. Proof of share ownership is provided by means of a relevant certificate issued by the Electronic Registry System. Share ownership need be in effect on August 30, 2018 (“record date”), ie at the start of the fourth day prior to the assembly date of September 03, 2018, while the share ownership certificate need be deposited to the Company at least three days prior to the assembly date, ie on August 31, 2018 at the latest.

Participation and voting rights for the First Repeat Extraordinary General Meeting of the Company’s shareholders are only offered to investors bearing shareholder status on the record date of August 30, 2018. In the event of non-compliance to article 28a of Law2190/1920 and its amendments, shareholders require assembly permission to participate. Exercise of participation and voting rights does not require impounding or any other form of withdrawal of shares from free trading between the registry date and the assembly date.

Each share bears the right for one vote.

II. PARTICIPATION AND VOTING THROUGH PROXY

Shareholders participating in the general meeting may vote in person or via proxy. Each private shareholder may appoint up to three proxies, and legal entities may appoint up to three persons as proxies. In the event that a shareholder owns shares which appear on more than one investor accounts, this does not limit the shareholder from appointing different proxies for each investor account. A proxy acting on behalf of more than one shareholder, may vote differently for each shareholder.

The Corporate Charter does not provide for the participation to the general meeting of shareholders by electronic means without their physical presence at the assembly venue, via remote electronic voting or by mail, and does not allow for appointing and recalling proxies by electronic means.

A proxy statement form is available for shareholders in paper form at the Company’s Investor Service (16 Amarousiou-Halandriou Street, 15125, Marousi, Greece, tel +30 210 6375000 and in electronic form at the company website www.jp-avax.gr

The proxy statement form should be filled, signed and deposited to the Company or sent via email to zaplanti@jp-avax.gr at least three days prior to the assembly date, ie up to August 31, 2018.

Proxies are required to inform the Company prior to the start of the general meeting of shareholders of any event which may be useful for shareholders in assessing the risk of the proxy serving other interests besides those of the represented shareholder. Conflict of interest may arise particularly if the proxy is:

1. a shareholder controlling the Company or is an entity controlled by that shareholder

2. a member of the Board of Directors of the Company or a senior director or a director to an entity controlling the Company or other entity which controls the Company

3. an employee or certified auditor of the Company or a shareholder controlling the Company or other entity which is in turn controlled by the controlling shareholder

4. a spouse or relative up to first degree of a person referred to in cases 1 to 3 above.

III. SHAREHOLDERS’ MINORITY RIGHTS

v Following a petition by shareholders representing 1/20 of the Company’s share capital, the Board of Directors:

o is required to append items to the agenda of the general meeting which is already published, provided the petition has been deposited to the Board of Directors at least 15 days prior to the assembly date, ie until August 19, 2018. The appended items on the agenda must be published by the Board of Directors according to article 27 of Law 2190/1920 and its amendments a minimum of seven days prior to the general meeting, is until August 27, 2018. For companies listed on a stock exchange, the petition for additional items on the agenda should include a justification or a draft for approval by the general meeting, and the revised agenda must be published in a similar way to the initial agenda at least 13 days prior to the assembly date, ie up to August 21, 2018.

o as per article 27 para 3 of Law 2190/1920 and its amendments, makes available to shareholders at least six days prior to the assembly date, ie up to August 28, 2018, the draft of the decisions for items included in the initial or the revised agenda, provided the petition has been deposited to the Board of Directors at least seven days prior to the assembly date, ie up to August 27, 2018.

v Following a petition by any shareholder which is deposited to the Company at least five days prior to the general meeting, ie up to August 28, 2018, the Board of Directors is required to provide to shareholders at the general meeting all requested information for the Company’s business affairs, to the extend that this information is useful for evaluating the assembly agenda. The Board of Directors may chose to provide a general answer to each shareholder petition of similar content. There is no obligation to provide information when those matters are already available on the Company website, in particular in the form of Questions and Answers.

v Following a petition by shareholders representing 1/5 of the Company’s share capital, which is deposited to the Company at least five days prior to the assembly date, ie up to August 28, 2018, the Board of Directors is required to provide to shareholders at the general meeting information on the Company’s business activity and assets. The Board of Directors may refuse to provide this information citing a significant reason, which must be recorded at the assembly minutes.

It should be noted that the exercise of all rights mentioned in this invitation requires that investors provide evidence of their shareholder status and the number of shares under their control while exercising those rights. The shareholder certificate issued by “Hellenic Exchanges SA” is acceptable proof of shareholder status and control.

Further details regarding those rights and the terms of their exercise are available at the Company website www.jp-avax.gr

The forms which need be deposited at the general meeting as well as the drafts of decisions for each agenda item are available in print form at the Company’s Investor Service (16 Amarousiou-Halandriou Street, 15125, Marousi, Greece, tel +30 210 6375000), for receiving copies of the forms.

All of the documents as well as the present invitation, the total of outstanding shares and voting rights and proxy voting forms are also available in electronic form at the company website www.jp-avax.gr

Marousi, August 17, 2018

THE VICE CHAIRMAN AND MANAGING DIRECTOR

Konstantine Mitzalis

Search: